CD8A and neoplasm: Preclinical evidence indicates that intratumoral injection of the unadjuvanted influenza vaccine limits tumor progression in mice, sensitizes tumors resistant to checkpoint blockade, and increases the proportion of tumor antigen-specific CD8+ T cells and dendritic cells within the microenvironment of the tumor.